Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Humar

Showing results (141-150 of 235) with videos related to

Pageof 24
Sort By:
Transplantation|August 20, 2024
Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective StudyJavier T Solera, Victor H Ferreira, Carlos Cervera, et al.
Infection Control and Hospital Epidemiology|July 14, 2018
Risk factors for surgical site infection after kidney and pancreas transplantationYoichiro Natori, Salma Albahrani, Mohammed Alabdulla, et al.
The Journal of Infectious Diseases|September 8, 2018
Cytokine Profiles and Severity of Influenza Infection in Transplant RecipientsArnaud G L'Huillier, Victor H Ferreira, Cedric Hirzel, et al.
Clinical Transplantation|October 13, 2020
Long-lasting cluster of nosocomial pneumonia with a single Pneumocystis jirovecii genotype involving different organ allograft recipientsSeyed M Hosseini-Moghaddam, Philippe J Dufresne, Elaine Hunter Gutierrez, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2021
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipientsVictoria G Hall, Victor H Ferreira, Matthew Ierullo, et al.
Clinical Transplantation|March 13, 2021
Late-onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti-CMV prophylaxis required following late-onset allograft rejection?Mohammadreza Rahimishahmirzadi, Anthony M Jevnikar, Andrew A House, et al.
Nature Immunology|February 4, 2022
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responsesVictoria G Hall, Victor H Ferreira, Heidi Wood, et al.
Transplantation|February 22, 2020
Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy StrategySabina Herrera, Setareh Davoudi, Ali Farooq, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysisYoichiro Natori, Ali Alghamdi, Mahmood Tazari, et al.
Transplantation|March 20, 2009
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxisOriol Manuel, Deepali Kumar, George Moussa, et al.
Pageof 24

Showing results (141-150 of 235) with videos related to

Sort By:
Pageof 24
Transplantation|August 20, 2024
Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective StudyJavier T Solera, Victor H Ferreira, Carlos Cervera, et al.
Infection Control and Hospital Epidemiology|July 14, 2018
Risk factors for surgical site infection after kidney and pancreas transplantationYoichiro Natori, Salma Albahrani, Mohammed Alabdulla, et al.
The Journal of Infectious Diseases|September 8, 2018
Cytokine Profiles and Severity of Influenza Infection in Transplant RecipientsArnaud G L'Huillier, Victor H Ferreira, Cedric Hirzel, et al.
Clinical Transplantation|October 13, 2020
Long-lasting cluster of nosocomial pneumonia with a single Pneumocystis jirovecii genotype involving different organ allograft recipientsSeyed M Hosseini-Moghaddam, Philippe J Dufresne, Elaine Hunter Gutierrez, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2021
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipientsVictoria G Hall, Victor H Ferreira, Matthew Ierullo, et al.
Clinical Transplantation|March 13, 2021
Late-onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti-CMV prophylaxis required following late-onset allograft rejection?Mohammadreza Rahimishahmirzadi, Anthony M Jevnikar, Andrew A House, et al.
Nature Immunology|February 4, 2022
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responsesVictoria G Hall, Victor H Ferreira, Heidi Wood, et al.
Transplantation|February 22, 2020
Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy StrategySabina Herrera, Setareh Davoudi, Ali Farooq, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysisYoichiro Natori, Ali Alghamdi, Mahmood Tazari, et al.
Transplantation|March 20, 2009
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxisOriol Manuel, Deepali Kumar, George Moussa, et al.
Pageof 24